MAPK3 and glomerular disorder: A recent study by Das et al. [13] demonstrated that activation of the TGF-β-ERK1/2-mTORC1 axis plays a key role in promoting podocyte injury and proteinuria in experimental models of glomerular disease, highlighting the pathogenic relevance of these signaling pathways in glomerular permeability and sclerosis.